메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학위논문
저자정보

홍미나 (부산대학교, 부산대학교 대학원)

지도교수
최준용
발행연도
2017
저작권
부산대학교 논문은 저작권에 의해 보호받습니다.

이용수24

표지
AI에게 요청하기
추천
검색

이 논문의 연구 히스토리 (2)

초록· 키워드

오류제보하기
Volume 1

Objective: The purpose of this study was to assess the change of symptoms and quality of life(QOL) of patients with lung cancer after chemotherapy treatment and to research the experiences about complementary and alternative medicine use.
Methods: The symptoms and quality of life were assessed using the questionnaires Quality-of-Life Questionnaire-Core 30 (QLQ-C30) and Lung Cancer Module (LC13), version 3.0. And questionnaire developed by researchers was used to assess the experiences of lung cancer patients who receive chemotherapy treatment about complementary and alternative medicine use. For the data analysis, the SPSS 22.0 program was used. Actual number as well as the percentage, mean, standard deviation, paired t-test and Wilcoxon signed rank test were used for statistical analysis.
Results: There were 24 male and 4 female participants and an average age was 64.2 years (46-80 years). During chemotherapy, there was a clinically-significant improvement in the emotional function, in the symptoms of insomnia, appetite loss and cough. However, improvement of appetite loss and cough was probably due in part to usage of oral medications. Clinically there was an aggravation of the function scales of physical and role function and of the symptoms of dyspnea, constipation and diarrhea. Nausea and vomiting, peripheral neuropathy and alopecia significantly deteriorated during chemotherapy. 14.3% of patients in the study used complementary and alternative medicine. 39.3% of patients wanted to use complementary and alternative medicine with chemotherapy and as the chief reason for choosing these therapies, 81.9% of those had an expectation that these therapies would be effective in treating symptoms or improving disease.
Conclusions: There were the symptoms which were aggravated because of the toxicity of the chemotherapy medications. To reduce the symptoms and treat the disease, some lung cancer patients have willing to use complementary and alternative medicine with chemotherapy.

목차

Volume 1
Ⅰ. 서론 1
Ⅱ. 연구방법 3
1. 연구설계 3
2. 연구대상 3
3. 자료수집 4
4. 연구도구 5
5. 자료분석방법 6
Ⅲ. 연구결과 7
1. 대상자의 일반적 특성 및 의학적 특성 7
2. 측정도구의 신뢰도 평가 9
3. 대상자의 삶의 질 및 증상의 변화 10
4. 대상자의 한의학 및 보완대체의료 이용경험 실태 12
5. 향후 항암화학요법과 한의학 및 보완대체의료의 병행 여부 14
Ⅳ. 고찰 18
Ⅴ. 결론 23
참고문헌 25
부록 29
Abstract 40
Volume 2
Ⅰ. 서론 1
Ⅱ. 연구방법 2
1. 연구설계 2
2. 연구대상 2
3. 연구과정 2
1) 1단계 : 통합의학 임상경로 준거틀 구성 2
2) 2단계 : 예비 통합의학 임상경로 개발 3
3) 3단계 : 전문가 집단의 내용 타당도 검증 3
4) 4단계 : 최종 통합의학 임상경로 개발 3
Ⅲ. 연구결과 4
1. 1단계 : 통합의학 임상경로 준거틀 구성 4
2. 2단계 : 예비 통합의학 임상경로 개발 4
3. 3단계 : 전문가 집단의 내용 타당도 검증 9
4. 4단계 : 최종 통합의학 임상경로 개발 10
Ⅳ. 고찰 11
Ⅴ. 결론 14
참고문헌 17
부록 21
APPENDIX 1. Questionnaire for content validity 21
APPENDIX 2. Content validity of preliminary critical pathway 27
APPENDIX 3. Critical Pathway for lung cancer patients treated with chemotherapy 32
Abstract 39

최근 본 자료

전체보기

댓글(0)

0